04/29/2025 13:00
KnowBe4 Appoints Bryan Palma as President and CEO

KnowBe4, the world-renowned cybersecurity platform that comprehensively addresses human risk management, announced that cybersecurity industry veteran Bryan Palma has been appointed president and chief executive officer of KnowBe4, effective May 5. KnowBe4’s founder and current chief executive officer Stu Sjouwerman has transitioned to the role of executive chairman. Palma is a highly regarded technology executive with over twenty-five years of experience and a proven track record of scaling g...

04/29/2025 13:00
Boomi CEO Steve Lucas’ New Book ‘Digital Impact’ Becomes a National Bestseller, Topping USA Today and Publishers Weekly Lists

Boomi™, the intelligent integration and automation leader, today announced that Chairman and CEO Steve Lucas is now a national bestselling author with the release of his new book, Digital Impact: The Human Element of AI-Driven Transformation (Wiley). Since its debut, the book has rapidly climbed national bestseller charts — including multiple appearances on USA TODAY’s Bestselling Books lists, and Publishers Weekly Bestseller List. Digital Impact resonates deeply with business leaders navigatin...

04/29/2025 13:00
Solving Border Control Staffing Challenges: Regula Launches an Ecosystem for Remote Document Examination

Regula, a global developer of forensic devices and identity verification solutions, introduces an innovative solution designed to transform document examination processes, particularly in border control operations. Based on high-resolution photospectral scanners from the Regula 88XX product line, it enables highly accurate and reliable remote document authentication, effectively addressing the pressing issue of staffing shortages in border security. This press release features multimedia. View ...

05/08/2025 14:00
WHOOP Unveils WHOOP® 5.0 and WHOOP® MG: Powerful New Devices with Breakthrough Health and Longevity Features

WHOOP, the human performance company, today introduces WHOOP 5.0 and WHOOP MG — two next-generation wearables designed to unlock a new approach to personal health and longevity. Paired with a redesigned WHOOP experience, the devices offer 14-day battery life in a sleeker, seven percent smaller form - and introduce category-defining features, including Healthspan with WHOOP Age, Heart Screener with on-demand ECG, Blood Pressure Insights, and more. This press release features multimedia. View the...

05/27/2025 12:00
Adtran launches Ensemble Cloudlet vRouter for rapid delivery of enterprise edge services

Adtran today launched its Ensemble Cloudlet vRouter, a cloud-managed solution that enables providers to deliver high-performance Layer 3 managed services with less cost, complexity and risk. As traditional routers reach end-of-life and core network revenues remain flat, providers are looking to enterprise sites to drive new growth. Delivered through a single subscription, the new solution offers a lower-cost alternative to proprietary appliances while enabling smarter service delivery, faster r...

05/27/2025 12:00
ITRS Launches Distributed Tracing to Automate Root Cause Analysis in Hybrid IT Environments

ITRS, the global leader in real-time monitoring and observability for mission-critical, highly regulated environments, announced the release of Distributed Tracing powered by OpenTelemetry (OTel). This industry-standard, open-source approach underpins powerful new capabilities within the ITRS Analytics platform, to give enterprise IT teams deep, end-to-end visibility across microservices, APIs, containers, databases, and legacy systems, without locking them into proprietary agents or limited in...

06/02/2025 11:00
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis

ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) application to initiate a Phase 2 clinical trial evaluating the safety and efficacy of IM-101, a novel complement C5 inhibitor, for the treatment of Myasthenia Gravis. The forthcoming multicenter, randomized, double-blind, placebo-controlled study will enroll up to 90 patients to evaluate the effecti...

06/02/2025 11:00
Lenovo and Bellevue University Team Up to Offer Supply Chain and Logistics Education to Deliver “Smarter Technology for All”

Lenovo, the global technology powerhouse, recognized in the top 10 in the Gartner Supply Chain Top 25, and Bellevue University, one of the nation’s top online universities, are teaming up to develop the next generation of supply chain professionals. “We believe that bringing real-world Global Supply Chain experience and learning directly into an education curriculum is precisely the optimal way to upskill the workforce of the future,” said Ben Massie, Vice President, Global Supply Chain, Leno...